Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04491604 |
|---|---|
| Brief Title: | The Objective of This Study is to Compare the Efficacy and Safety of Beremagene Geperpavec (B-VEC) Topical Gel With That of Placebo for the Treatment of Dystrophic Epidermolysis Bullosa (DEB). |
| First Submitted : | July 22, 2020 |
| First Submitted that Met QC Criteria : | July 27, 2020 |
| First Posted : | July 29, 2020 |
| Last Update Submitted that Met QC Criteria : | July 27, 2020 |
| Last Update Posted : | July 29, 2020 |